Recognizing and treating neuropsychiatric symptoms in parkinson's disease

Research output: Contribution to journalArticle

Abstract

• Objective: To review the clinical characteristics, epidemiology, and management of the most common neuropsychiatric symptoms (NPS) in Parkinson's disease (PD). • Methods: Literature review. • Results: PD has traditionally been considered a disease of impaired motor function. However, neuropsychiatric complications, such as fatigue, depression, anxiety, psychosis, impulse control disorders, and apathy, frequently complicate the course of the illness. Although the development of new medication options in recent years has had a positive benefit on the management of these troublesome symptoms, responses are frequently suboptimal. The development of valid instruments to measure neuropsychiatric symptoms has been vital in research efforts to bridge the gaps in our understanding. Further elucidation of neuropsychiatric pathophysiologies will help to define treatment targets and has the potential to expand our therapeutic armamentarium. • Conclusion: While NPS affect patients with established disease, recent investigations have demonstrated risk of symptoms in those with early untreated stages of PD; therefore, better understanding of NPS should be the goal of practitioners treating the entire continuum of PD.

Original languageEnglish (US)
Pages (from-to)323-334
Number of pages12
JournalJournal of Clinical Outcomes Management
Volume22
Issue number7
StatePublished - Jul 1 2015

Fingerprint

Parkinson Disease
Disruptive, Impulse Control, and Conduct Disorders
Apathy
Psychotic Disorders
Fatigue
Epidemiology
Anxiety
Depression
Therapeutics
Research

ASJC Scopus subject areas

  • Medicine(all)
  • Health Policy

Cite this

Recognizing and treating neuropsychiatric symptoms in parkinson's disease. / Chung, Kathryn (Kathy).

In: Journal of Clinical Outcomes Management, Vol. 22, No. 7, 01.07.2015, p. 323-334.

Research output: Contribution to journalArticle

@article{df500d13e25e4f6fa0b9077bcb5bddb6,
title = "Recognizing and treating neuropsychiatric symptoms in parkinson's disease",
abstract = "• Objective: To review the clinical characteristics, epidemiology, and management of the most common neuropsychiatric symptoms (NPS) in Parkinson's disease (PD). • Methods: Literature review. • Results: PD has traditionally been considered a disease of impaired motor function. However, neuropsychiatric complications, such as fatigue, depression, anxiety, psychosis, impulse control disorders, and apathy, frequently complicate the course of the illness. Although the development of new medication options in recent years has had a positive benefit on the management of these troublesome symptoms, responses are frequently suboptimal. The development of valid instruments to measure neuropsychiatric symptoms has been vital in research efforts to bridge the gaps in our understanding. Further elucidation of neuropsychiatric pathophysiologies will help to define treatment targets and has the potential to expand our therapeutic armamentarium. • Conclusion: While NPS affect patients with established disease, recent investigations have demonstrated risk of symptoms in those with early untreated stages of PD; therefore, better understanding of NPS should be the goal of practitioners treating the entire continuum of PD.",
author = "Chung, {Kathryn (Kathy)}",
year = "2015",
month = "7",
day = "1",
language = "English (US)",
volume = "22",
pages = "323--334",
journal = "Journal of Clinical Outcomes Management",
issn = "1079-6533",
publisher = "Turner White Communications Inc.",
number = "7",

}

TY - JOUR

T1 - Recognizing and treating neuropsychiatric symptoms in parkinson's disease

AU - Chung, Kathryn (Kathy)

PY - 2015/7/1

Y1 - 2015/7/1

N2 - • Objective: To review the clinical characteristics, epidemiology, and management of the most common neuropsychiatric symptoms (NPS) in Parkinson's disease (PD). • Methods: Literature review. • Results: PD has traditionally been considered a disease of impaired motor function. However, neuropsychiatric complications, such as fatigue, depression, anxiety, psychosis, impulse control disorders, and apathy, frequently complicate the course of the illness. Although the development of new medication options in recent years has had a positive benefit on the management of these troublesome symptoms, responses are frequently suboptimal. The development of valid instruments to measure neuropsychiatric symptoms has been vital in research efforts to bridge the gaps in our understanding. Further elucidation of neuropsychiatric pathophysiologies will help to define treatment targets and has the potential to expand our therapeutic armamentarium. • Conclusion: While NPS affect patients with established disease, recent investigations have demonstrated risk of symptoms in those with early untreated stages of PD; therefore, better understanding of NPS should be the goal of practitioners treating the entire continuum of PD.

AB - • Objective: To review the clinical characteristics, epidemiology, and management of the most common neuropsychiatric symptoms (NPS) in Parkinson's disease (PD). • Methods: Literature review. • Results: PD has traditionally been considered a disease of impaired motor function. However, neuropsychiatric complications, such as fatigue, depression, anxiety, psychosis, impulse control disorders, and apathy, frequently complicate the course of the illness. Although the development of new medication options in recent years has had a positive benefit on the management of these troublesome symptoms, responses are frequently suboptimal. The development of valid instruments to measure neuropsychiatric symptoms has been vital in research efforts to bridge the gaps in our understanding. Further elucidation of neuropsychiatric pathophysiologies will help to define treatment targets and has the potential to expand our therapeutic armamentarium. • Conclusion: While NPS affect patients with established disease, recent investigations have demonstrated risk of symptoms in those with early untreated stages of PD; therefore, better understanding of NPS should be the goal of practitioners treating the entire continuum of PD.

UR - http://www.scopus.com/inward/record.url?scp=84936885853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84936885853&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84936885853

VL - 22

SP - 323

EP - 334

JO - Journal of Clinical Outcomes Management

JF - Journal of Clinical Outcomes Management

SN - 1079-6533

IS - 7

ER -